NCT06214559View on ClinicalTrials.gov

Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions

WartsPlantar WartCommon Wart

Interventions

DEVICE

Sérum VERRUPRO

To be applied twice a day

Trial Locations (2)

1082

L'Activité Privée Complémentaire (APC) Habib Thameur hospital, Tunis

2074

Private practice, Tunis

All Listed Sponsors

lead

Swiss Footcare Laboratories - Poderm Professional

INDUSTRY

NCT06214559 - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | Biotech Hunter | Biotech Hunter